{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:09:51Z","timestamp":1784761791434,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.bbmt.2014.08.002","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T08:16:59Z","timestamp":1407485819000},"page":"1926-1931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Plerixafor and Abbreviated-Course Granulocyte Colony\u2013Stimulating Factor for Mobilizing Hematopoietic Progenitor Cells in Light Chain Amyloidosis"],"prefix":"10.1016","volume":"20","author":[{"given":"Binod","family":"Dhakal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Strouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Arce-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanie","family":"Esselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Drobyski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Douglas","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswaran N.","family":"Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-510X","authenticated-orcid":false,"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.08.002_bib1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.08.002_bib2","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood-2003-12-4192","article-title":"Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study","volume":"103","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.08.002_bib3","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1182\/blood-2011-01-330738","article-title":"Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients","volume":"118","author":"Cibeira","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.08.002_bib4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/bmt.2011.152","article-title":"Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis","volume":"47","author":"Schonland","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.08.002_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bmt.2013.192","article-title":"Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement","volume":"49","author":"Girnius","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.08.002_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJMc072918","article-title":"High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis","volume":"358","author":"Lachmann","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.08.002_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4065\/mcp.2010.0480","article-title":"Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score","volume":"86","author":"Kumar","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bbmt.2014.08.002_bib8","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/bmt.2013.53","article-title":"Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center","volume":"48","author":"Dispenzieri","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.08.002_bib9","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1182\/blood-2013-01-453001","article-title":"Systemic light chain amyloidosis: an update for treating physicians","volume":"121","author":"Merlini","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.08.002_bib10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ajh.23400","article-title":"Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment","volume":"88","author":"Gertz","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2014.08.002_bib11","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2009-04-202879","article-title":"How I treat amyloidosis","volume":"114","author":"Comenzo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.08.002_bib12","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V91.10.3662","article-title":"Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients","volume":"91","author":"Comenzo","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.08.002_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.bmt.1704344","article-title":"Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome","volume":"33","author":"Mollee","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.08.002_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbmt.2013.11.015","article-title":"Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosis","volume":"20","author":"Devine","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.08.002_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa070484","article-title":"High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis","volume":"357","author":"Jaccard","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.08.002_bib16","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1200\/JCO.2010.31.4161","article-title":"Primary systemic amyloid light chain amyloidosis decompensating after filgrastim-induced mobilization and stem-cell collection","volume":"29","author":"Bashir","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.08.002_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2141.1999.01216.x","article-title":"Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis","volume":"104","author":"Comenzo","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.08.002_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbmt.2014.08.002_bib19","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1182\/blood-2005-03-1206","article-title":"Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients","volume":"106","author":"Leung","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.08.002_bib20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1537-2995.2005.00597.x","article-title":"Peripheral blood progenitor cell mobilization and collection in 42 patients with primary systemic amyloidosis","volume":"45","author":"Perotti","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2014.08.002_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000354132","article-title":"Physiology and pharmacology of plerixafor","volume":"40","author":"Fricker","year":"2013","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.bbmt.2014.08.002_bib22","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.08.002_bib23","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","volume":"27","author":"DiPersio","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.08.002_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","article-title":"The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering","volume":"5","author":"Sutherland","year":"1996","journal-title":"J\u00a0Hematother"},{"key":"10.1016\/j.bbmt.2014.08.002_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/cyto.b.20351","article-title":"Flow cytometric CD34+ stem cell enumeration: lessons from nine years' external quality assessment within the Benelux countries","volume":"72","author":"Levering","year":"2007","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.bbmt.2014.08.002_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study","volume":"140","author":"Skinner","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2014.08.002_bib27","first-page":"9","article-title":"Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis","volume":"2","author":"Sanchorawala","year":"2012","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.bbmt.2014.08.002_bib28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1702005","article-title":"High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant","volume":"24","author":"Saba","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.08.002_bib29","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus double autologous stem-cell transplantation for multiple myeloma","volume":"349","author":"Attal","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.08.002_bib30","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/1078-0432.1210.11.3","article-title":"Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis","volume":"11","author":"Porrata","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2014.08.002_bib31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/bmt.2011.226","article-title":"Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease","volume":"47","author":"Dunn","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.08.002_bib32","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.bbmt.2008.12.030","article-title":"Comparison of graft durability among lymphoma patients who received plerixafor in combination with G-CSF for primary versus failed mobilization","volume":"15","author":"Micallef","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.08.002_bib33","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/bmt.2013.52","article-title":"Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies","volume":"48","author":"Awan","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.08.002_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/bmt.2010.78","article-title":"Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization","volume":"46","author":"Costa","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.08.002_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.transci.2012.03.011","volume":"46","author":"Varmavuo","year":"2012","journal-title":"Transfus Apher Sci"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114005011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114005011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:48:42Z","timestamp":1761058122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879114005011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1083879114005011"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.08.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plerixafor and Abbreviated-Course Granulocyte Colony\u2013Stimulating Factor for Mobilizing Hematopoietic Progenitor Cells in Light Chain Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}